Meet us at Rewired 2025
18 March 2025 - 19 March 2025
Exhibition
Norway is at the forefront of digital health, offering solutions that enhance patient care, improve efficiency and drive innovation. Meet us at stand J60!
Three leading Norwegian companies will be at stand J60, showcasing their expertise:
- DNV Imatis – Providing real-time digital workflow solutions for hospitals and care facilities, improving operational efficiency and enhancing communication between healthcare providers.
- Checkware – Delivering digital patient pathways and remote care solutions, enabling healthcare providers to offer continuous monitoring and follow-up beyond traditional healthcare settings.
- Vitalthings – Developing advanced, contact-free monitoring solutions for sleep and vital signs, supporting early detection and improved patient management in hospitals and home care.
Book a 1:1 Meeting
Want to explore how Norwegian digital health solutions can support your goals? Book a 1:1 meeting with DNV Imatis, Checkware, VitalThings or our Innovation Norway representative to discuss opportunities, collaborations and insights.
🔗 Book your meeting now
Find us at Rewired 2025 to learn more about how Norwegian digital health solutions are contributing to a smarter, more connected healthcare system.
Explore solutions
All times are in GMT
1:1 Meetings
08:00 - 18:00
08:00 - 18:00
Exhibitors
Organisers
INNOVATION NORWAY
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.